17 results
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... - Management and ... Superficial #Deep #VTE #DVT ... #Hematology #Management ... #Anatomy #Anticoagulation
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... - Management and ... Superficial #Deep #VTE #DVT ... #Hematology #Management ... #Anatomy #Anticoagulation
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... During Anticoagulation ... Behcet's disease - APLS ... - May-Thurner syndrome ... #hematology #differential
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... ) APS Venous Thrombosis ... Antiphospholipid #Syndrome ... #APS #management ... #hematology #treatment
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Antiphospholipid Syndrome ... at least: • 1 clinical ... or small-vessel thrombosis ... presence of 1 clinical ... #management #anticoagulation
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management ... Algorithm #Anticoagulation ... #Breakthrough #Thrombosis ... Extension #VTE #DVT ... #Hematology #Management
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
/Muscular Vein Thrombosis ... syndrome - ... Bloodman #VTE #anticoagulation ... #duration #management ... #DVT #hematology
Differential diagnosis of schistocytes / fragmentation hemolysis:
 • Thrombotic microangiopathies (TMA)
    - TTP
hemolysis: • Thrombotic ... hemolytic-uremic syndrome ... (ST-HUS) - ... - Drug-induced thrombotic ... differential #diagnosis #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
cancer-associated thrombosis ... DVT = deep vein ... thrombosis; PE = ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... catheter-related thrombosis ... without concomitant DVT ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology